Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples